BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Souza MS. Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits. Front Psychiatry 2019;10:509. [PMID: 31396113 DOI: 10.3389/fpsyt.2019.00509] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kou XL, Tao Y, Xian JY, Lin YH, Cai CY, Wu HY, Chang L, Zhu DY. Uncoupling nNOS-PSD-95 in mPFC inhibits morphine priming-induced reinstatement after extinction training. Biochem Biophys Res Commun 2020;525:520-7. [PMID: 32113678 DOI: 10.1016/j.bbrc.2020.02.112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 de Miquel C, Pross B, Papazova I, Güler D, Hasan A. The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects. Eur Arch Psychiatry Clin Neurosci 2021;271:157-80. [PMID: 32594235 DOI: 10.1007/s00406-020-01155-6] [Reference Citation Analysis]
3 Yan-Guang Y, Jing-Yi C, Xiao-Wu P, Meng-Lu S, Su-Yong Y, Ding X, Ke X, Tian-Yuan W, Jia-Bin W, Dong Z. Comparison of physical effect between two training methods for individuals with substance use disorder. BMC Sports Sci Med Rehabil 2021;13:6. [PMID: 33478548 DOI: 10.1186/s13102-021-00234-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kashyap B, Hanson LR, Frey Ii WH. Intranasal Insulin: a Treatment Strategy for Addiction. Neurotherapeutics 2020;17:105-15. [PMID: 31898283 DOI: 10.1007/s13311-019-00822-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Wang H, Cao D, Gillespie JC, Mendez RE, Selley DE, Liu-Chen LY, Zhang Y. Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators. Future Med Chem 2021;13:551-73. [PMID: 33590767 DOI: 10.4155/fmc-2020-0308] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rizkallah E, Mongeau-pérusse V, Lamanuzzi L, Castenada-ouellet S, Stip E, Juteau L, Brissette S, Bruneau J, Dubreucq S, Jutras-aswad D. Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial. Pharmacology Biochemistry and Behavior 2022;216:173376. [DOI: 10.1016/j.pbb.2022.173376] [Reference Citation Analysis]
7 De Sa Nogueira D, Bourdy R, Alcala-Vida R, Filliol D, Andry V, Goumon Y, Zwiller J, Romieu P, Merienne K, Olmstead MC, Befort K. Hippocampal Cannabinoid 1 Receptors Are Modulated Following Cocaine Self-administration in Male Rats. Mol Neurobiol 2022. [PMID: 35032317 DOI: 10.1007/s12035-022-02722-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nesbit MO, Phillips AG. Tetrahydroprotoberberines: A Novel Source of Pharmacotherapies for Substance Use Disorders? Trends Pharmacol Sci 2020;41:147-61. [PMID: 31987662 DOI: 10.1016/j.tips.2019.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Petković B, Kesić S, Pešić V. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder. Curr Pharm Des 2020;26:466-84. [PMID: 31939725 DOI: 10.2174/1381612826666200115094642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]